OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Sunil V. Badve, Anika Bilal, Matthew M.Y. Lee, et al.
The Lancet Diabetes & Endocrinology (2024)
Closed Access | Times Cited: 11
Sunil V. Badve, Anika Bilal, Matthew M.Y. Lee, et al.
The Lancet Diabetes & Endocrinology (2024)
Closed Access | Times Cited: 11
Showing 11 citing articles:
Glucagon like peptide-1 (GLP-1) agonists and cardiometabolic protection: historical development and future challenges
Francisco Westermeier, Enrique Z. Fisman
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Francisco Westermeier, Enrique Z. Fisman
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2025) Vol. 187, pp. 171380-171380
Open Access | Times Cited: 1
Clifford J. Bailey, Peter R. Flatt, J. Michael Conlon
Peptides (2025) Vol. 187, pp. 171380-171380
Open Access | Times Cited: 1
Adipocentric Strategy for the Treatment of Type 2 Diabetes Mellitus
Juan José Gorgojo MartÃnez
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 678-678
Open Access
Juan José Gorgojo MartÃnez
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 678-678
Open Access
Do novel antidiabetic therapies reduce the risk of contrast-associated acute kidney injury?
Anand Shah, George A. Stouffer
The American Journal of Cardiology (2025)
Closed Access
Anand Shah, George A. Stouffer
The American Journal of Cardiology (2025)
Closed Access
Glucagon-like peptide-1 receptor agonism and end-organ protection
Samuel J. Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
Samuel J. Daniels, Cecilia Karlsson, Patrick Schrauwen, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
Anti-obesity drugs for the gastroenterologists
Lisa Sharkey
Frontline Gastroenterology (2025), pp. flgastro-102995
Closed Access
Lisa Sharkey
Frontline Gastroenterology (2025), pp. flgastro-102995
Closed Access
Nutraceuticals for Cardiometabolic Diseases: Prophylactic and Therapeutic Research
Ronan Lordan
Nutraceuticals (2025) Vol. 5, Iss. 1, pp. 8-8
Open Access
Ronan Lordan
Nutraceuticals (2025) Vol. 5, Iss. 1, pp. 8-8
Open Access
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
Darren K. McGuire, Nikolaus Marx, Sharon L. Mulvagh, et al.
New England Journal of Medicine (2025)
Closed Access
Darren K. McGuire, Nikolaus Marx, Sharon L. Mulvagh, et al.
New England Journal of Medicine (2025)
Closed Access
6. CARDIO-RENAL PROTECTION IN TYPE 2 DIABETES
Stephen Colagiuri, Antonio Ceriello
Diabetes Research and Clinical Practice (2025), pp. 112150-112150
Closed Access
Stephen Colagiuri, Antonio Ceriello
Diabetes Research and Clinical Practice (2025), pp. 112150-112150
Closed Access
Cardiovascular-Kidney-Metabolic Health
Melinda Solomon, Sophie E. Claudel, Ashish Verma
Cardiology Clinics (2025)
Closed Access
Melinda Solomon, Sophie E. Claudel, Ashish Verma
Cardiology Clinics (2025)
Closed Access
Metabolic, Renal, and Inflammatory Crosstalk in Atherosclerotic Cardiovascular Disease: Evolving Landscape and Future Directions
Harris Avgousti, Matthew J. Feinstein
Atherosclerosis (2025), pp. 119199-119199
Closed Access
Harris Avgousti, Matthew J. Feinstein
Atherosclerosis (2025), pp. 119199-119199
Closed Access
Oral semaglutide and reduction in major adverse cardiovascular events
P. Barton Duell, Kevin C. Maki
Journal of clinical lipidology (2025) Vol. 19, Iss. 2, pp. 195-196
Closed Access
P. Barton Duell, Kevin C. Maki
Journal of clinical lipidology (2025) Vol. 19, Iss. 2, pp. 195-196
Closed Access
Expanding applications of GLP-1 therapies: a careful view
Domenico Azzolino, Tiziano Lucchi
International Journal of Obesity (2025)
Closed Access
Domenico Azzolino, Tiziano Lucchi
International Journal of Obesity (2025)
Closed Access
Cardiovascular risk, meet the twins: Optimizing cardiometabolic care with SGLT2i and GLP-1RA combination therapy
Paschalis Karakasis, Dimitrios Patoulias, Panagiotis Theofilis, et al.
International Journal of Cardiology (2025) Vol. 432, pp. 133272-133272
Closed Access
Paschalis Karakasis, Dimitrios Patoulias, Panagiotis Theofilis, et al.
International Journal of Cardiology (2025) Vol. 432, pp. 133272-133272
Closed Access
Weekly Journal Scan: a large observational study unravels the wide-ranging effects of glucagon-like peptide-1 receptor agonists
Daniela Pedicino, Massimo Volpe
European Heart Journal (2025)
Closed Access
Daniela Pedicino, Massimo Volpe
European Heart Journal (2025)
Closed Access
Promising results but caution needed in GLP-1RA large scale epidemiology
Naveed Sattar, Salil V. Deo
Trends in Endocrinology and Metabolism (2025)
Open Access
Naveed Sattar, Salil V. Deo
Trends in Endocrinology and Metabolism (2025)
Open Access
The promise and hope of GLP-1 receptor agonists
Priya Sumithran, Jamy D. Ard
The Lancet Diabetes & Endocrinology (2024)
Closed Access
Priya Sumithran, Jamy D. Ard
The Lancet Diabetes & Endocrinology (2024)
Closed Access
